Human medicines European public assessment report (EPAR): Oslif Breezhaler, indacaterol, Date of authorisation: 29/11/...
In three main studies involving over 4,000 patients with COPD, Oslif Breezhaler was compared with placebo (a dummy treatment), tiotropium or formoterol (other inhaled medicines used to treat COPD). The main measure of effectiveness was based on changes in …